1. Home
  2. CNOBP vs LYEL Comparison

CNOBP vs LYEL Comparison

Compare CNOBP & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNOBP
  • LYEL
  • Stock Information
  • Founded
  • CNOBP N/A
  • LYEL 2018
  • Country
  • CNOBP United States
  • LYEL United States
  • Employees
  • CNOBP 499
  • LYEL N/A
  • Industry
  • CNOBP Major Banks
  • LYEL Biotechnology: Pharmaceutical Preparations
  • Sector
  • CNOBP Finance
  • LYEL Health Care
  • Exchange
  • CNOBP Nasdaq
  • LYEL Nasdaq
  • Market Cap
  • CNOBP N/A
  • LYEL 263.9M
  • IPO Year
  • CNOBP N/A
  • LYEL 2021
  • Fundamental
  • Price
  • CNOBP $22.50
  • LYEL $0.65
  • Analyst Decision
  • CNOBP
  • LYEL Sell
  • Analyst Count
  • CNOBP 0
  • LYEL 2
  • Target Price
  • CNOBP N/A
  • LYEL $1.00
  • AVG Volume (30 Days)
  • CNOBP N/A
  • LYEL 1.3M
  • Earning Date
  • CNOBP N/A
  • LYEL 02-26-2025
  • Dividend Yield
  • CNOBP N/A
  • LYEL N/A
  • EPS Growth
  • CNOBP N/A
  • LYEL N/A
  • EPS
  • CNOBP N/A
  • LYEL N/A
  • Revenue
  • CNOBP N/A
  • LYEL $63,000.00
  • Revenue This Year
  • CNOBP N/A
  • LYEL N/A
  • Revenue Next Year
  • CNOBP N/A
  • LYEL N/A
  • P/E Ratio
  • CNOBP N/A
  • LYEL N/A
  • Revenue Growth
  • CNOBP N/A
  • LYEL N/A
  • 52 Week Low
  • CNOBP N/A
  • LYEL $0.58
  • 52 Week High
  • CNOBP N/A
  • LYEL $3.26
  • Technical
  • Relative Strength Index (RSI)
  • CNOBP 57.48
  • LYEL 34.74
  • Support Level
  • CNOBP $22.09
  • LYEL $0.60
  • Resistance Level
  • CNOBP $22.97
  • LYEL $0.71
  • Average True Range (ATR)
  • CNOBP 0.15
  • LYEL 0.06
  • MACD
  • CNOBP 0.01
  • LYEL 0.01
  • Stochastic Oscillator
  • CNOBP 46.59
  • LYEL 23.51

About CNOBP ConnectOne Bancorp Inc. Depositary Shares each representing a 1/40th interest in a share of 5.25% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series A

ConnectOne Bancorp Inc is a holding company. The company through its holding provides banking services including lending, depository, and related financial services to commercial, industrial and governmental customers. It is managed as one segment: a community bank. It generates revenue from net interest income.

About LYEL Lyell Immunopharma Inc.

Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.

Share on Social Networks: